Lipocine Inc. company info

CIK 1535955
IRS Number 990370688
State of incorporation DE
Business address 675 ARAPEEN DRIVE, SUITE 202
Mail address 675 ARAPEEN DRIVE, SUITE 202

Short summary

Lipocine Inc. is a X1 company, with head office located at 675 Arapeen Drive, Suite 202 Salt Lake City, X1 84108. In 2019 the company owned a total of 20.99 million USD worth of assets, including 20.97 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

Lipocine Inc. Income Statement

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Research and development
Operating Expenses 3.8310.6820.4818.3819.1921.2211.7513.07
Operating Income (Loss) -2.333.88-10.68-20.48-18.38-19.19-21.22-11.33-12.90
Other Nonoperating Income (Expense) 0.220.24-0.33-0.34
Income Tax Expense (Benefit) 0.020.00-
Net income -2.25-0.08-10.59-20.37-18.21-18.97-20.98-11.66-13.01

Lipocine Inc. Balance Sheet

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Cash and cash equivalents
Available-for-sale Securities, Current 5.5720.5711.1918.4910.81
Accounts Receivable, Net, Current 0.310.09
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.961.
Available-for-sale Securities, Noncurrent 9.5400
Other Assets, Noncurrent
Total assets 9.110.0035.4953.8033.3528.0525.3019.6820.99
Current assets 0.030.0035.4444.1533.2027.9325.2519.6420.97
Accounts payable 0.150.590.640.400.991.110.410.121.65
Taxes Payable, Current -0.06
Total current liabilities 0.810.021.671.672.582.902.844.444.06
Long-term Debt, Excluding Current Maturities 8.585.384.69
Long-term Debt 108.335.83
Deferred Revenue, Noncurrent 6.96
Total liabilities 7.810.771.671.672.582.9011.429.8314.44
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -37.27-60.10-75.44-99.22-116.37-132.38-144.71-156.84
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.010.01-0.00-0.010.00-0.00

Lipocine Inc. Cash Flow

Name [in Millions USD]2010201120122013201420152016201720182019Trends
Net income -2.25-0.08-10.59-20.37-18.21-18.97-20.98-11.66-13.01
Depreciation and amortization
Deferred Income Tax Expense (Benefit) 0000000
Accounts receivable -0.41-0.310
Accounts payable -0.34-0.060.67-0.450.20-0.260.350.070.51
Deferred revenue 2.17-7.520
Net Cash Provided by (Used in) Operating Activities 1.40-3.18-8.59-15.36-18.28-16.70-12.08-11.67
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities -0.02-0.01-0.00-
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.00-0.04-25.023.23
Proceeds from Issuance of Common Stock 0.03012.81032.44010.640.658.00
Net Cash Provided by (Used in) Financing Activities 0.03048.4832.720.6111.2310.6510.32
Cash and Cash Equivalents, Period Increase (Decrease) 1.38-3.1939.89-17.60-7.66-14.45-2.359.87